Back to Search Start Over

Severe ranitidine-induced anaphylaxis: a case report and literature review

Authors :
Semir Nouira
N. Ben Fredj
Hamdi Boubaker
Naceur A. Boughattas
Wahid Bouida
Riadh Boukef
Amel Chaabane
Karim Aouam
Source :
Journal of Clinical Pharmacy and Therapeutics. 37:494-496
Publication Year :
2011
Publisher :
Hindawi Limited, 2011.

Abstract

Summary What is known and Objective: Ranitidine is a generally well-tolerated drug, and serious side effects are rare. However, ranitidine-induced anaphylaxis has been reported on rare occasions. We report on such a case and review other cases reported in the literature. Case summary: A 36-year-old man with no history of other medications, illnesses or allergic diseases, especially to drugs, consulted our emergency department because of renal colic and epigastric discomfort. He was given 50 mg of ranitidine as a slow intravenous bolus and 20 mg of piroxicam intramuscularly. Within the first minute, the patient developed a cold sweat, trembling, dyspnoea and deterioration of his consciousness. The condition was considered as an anaphylactic shock, and cardiopulmonary resuscitation and inotropic support were immediately commenced. Two days later, he was weaned off the ventilator as he was haemodynamically stable. He was discharged after 7 days. Four weeks later, skin prick tests to ranitidine and piroxicam were performed on the forearm of the patient. He reacted strongly to ranitidine about 10 min later but not to piroxicam. To assess cross-reactivity to other H2- and H1-receptor antagonists in our patient, we subsequently performed prick tests to famotidine, cimetidine and desloratadine and all were negative. What is new and Conclusion: We re-emphasize a potentially serious, albeit very rare, adverse effect of ranitidine and summarize other reported cases. This case demonstrates that commonly used, generally safe drugs may on occasions cause serious adverse effects.

Details

ISSN :
02694727
Volume :
37
Database :
OpenAIRE
Journal :
Journal of Clinical Pharmacy and Therapeutics
Accession number :
edsair.doi...........3d51323d29c5bb963c05bfbc0d8a4c59
Full Text :
https://doi.org/10.1111/j.1365-2710.2011.01320.x